X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (53) 53
female (43) 43
male (43) 43
cardiac & cardiovascular systems (37) 37
aged (36) 36
middle aged (35) 35
index medicus (29) 29
mortality (24) 24
outcomes (19) 19
treatment outcome (18) 18
heart failure (17) 17
hospitalization (17) 17
cardiovascular (16) 16
double-blind method (14) 14
prospective studies (14) 14
heart attacks (13) 13
heart failure - drug therapy (12) 12
risk factors (11) 11
therapy (11) 11
benzazepines - therapeutic use (10) 10
cardiology (10) 10
follow-up studies (10) 10
myocardial infarction (10) 10
percutaneous coronary intervention (10) 10
women (10) 10
abridged index medicus (9) 9
angioplasty (9) 9
antidiuretic hormone receptor antagonists (9) 9
cardiac patients (9) 9
care and treatment (9) 9
drug therapy (9) 9
electrocardiography (9) 9
adult (8) 8
aged, 80 and over (8) 8
clinical trials (8) 8
coronary artery disease (8) 8
coronary heart disease (8) 8
disease (8) 8
drug-eluting stents (8) 8
heart failure - mortality (8) 8
medicine, general & internal (8) 8
stent (8) 8
stents (8) 8
trial (8) 8
acute myocardial-infarction (7) 7
heart attack (7) 7
internal medicine (7) 7
kaplan-meier estimate (7) 7
myocardial infarction - therapy (7) 7
research (7) 7
cardiac and cardiovascular systems (6) 6
cardiovascular disease (6) 6
coronary angiography (6) 6
coronary disease (6) 6
heart failure - physiopathology (6) 6
kardiologi (6) 6
patient outcomes (6) 6
revascularization (6) 6
time factors (6) 6
acute coronary syndromes (5) 5
angioplasty, balloon, coronary - adverse effects (5) 5
bandages, dressings or absorbent pads (5) 5
cardiology and cardiovascular medicine (5) 5
clinical outcomes (5) 5
coronary vessels (5) 5
devices providing patency to, or preventing collapsing of,tubular structures of the body, e.g. stents (5) 5
diastolic function (5) 5
dosage and administration (5) 5
double-blind (5) 5
filters implantable into blood vessels (5) 5
first-aid kits (5) 5
fomentation (5) 5
gender (5) 5
health aspects (5) 5
human necessities (5) 5
hygiene (5) 5
management (5) 5
medical colleges (5) 5
medical or veterinary science (5) 5
multivariate analysis (5) 5
myocardial infarction - mortality (5) 5
orthopaedic, nursing or contraceptive devices (5) 5
prevalence (5) 5
prognosis (5) 5
prostheses (5) 5
risk (5) 5
sex factors (5) 5
studies (5) 5
thrombosis (5) 5
transluminal angioplasty (5) 5
treatment or protection of eyes or ears (5) 5
anticoagulants (4) 4
argentina (4) 4
association (4) 4
benzazepines/therapeutic use (4) 4
care (4) 4
clinical medicine (4) 4
coronary artery bypass (4) 4
coronary disease - drug therapy (4) 4
coronary disease - mortality (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 01/2013, Volume 381, Issue 9860, pp. 29 - 39
Journal Article
JAMA, ISSN 0098-7484, 03/2007, Volume 297, Issue 12, pp. 1319 - 1331
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 117, Issue 2, pp. 186 - 191
Women have higher bleeding complication and mortality rates after percutaneous coronary interventions (PCI). The contribution of female gender to bleeding and... 
Cardiovascular | HARMONIZING OUTCOMES | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | ACUTE CATHETERIZATION | STRATEGY | ACUTE MYOCARDIAL-INFARCTION | GLYCOPROTEIN IIB/IIIA RECEPTOR | POOLED ANALYSIS | BLOCKADE | GENDER-DIFFERENCES | PRIMARY ANGIOPLASTY | United States - epidemiology | Myocardial Infarction - mortality | Follow-Up Studies | Humans | Middle Aged | Hemorrhage - mortality | Argentina - epidemiology | Male | Antithrombins - administration & dosage | Recombinant Proteins - adverse effects | Hirudins - administration & dosage | Myocardial Infarction - therapy | Time Factors | Percutaneous Coronary Intervention - methods | Electrocardiography | Female | Survival Rate - trends | Peptide Fragments - administration & dosage | Risk Factors | Recombinant Proteins - administration & dosage | Antithrombins - adverse effects | Hirudins - adverse effects | Aged | Peptide Fragments - adverse effects | Hemorrhage - chemically induced | United Kingdom - epidemiology | Transluminal angioplasty | Women | Medical colleges | Glycosaminoglycans | Coronary artery bypass | Cardiac patients | Mortality | Anticoagulants (Medicine) | Health aspects | Coronary heart disease | Cardiovascular agents | Hypertension | Blood transfusions | Heart attacks | Medical imaging | Heart surgery | Gender | Multivariate analysis | Confidence intervals | Variables | Ischemia | Coronary vessels | Diabetes | Cardiology | Acute coronary syndromes | Veins & arteries
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2008, Volume 358, Issue 21, pp. 2205 - 2217
Immediate percutaneous coronary intervention (PCI) is the treatment of choice for acute ST-segment elevation myocardial infarction. In this study, PCI that was... 
IMMEDIATE ANGIOPLASTY | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | TO-BALLOON TIME | 30-DAY MORTALITY | INTRAVENOUS THROMBOLYTIC THERAPY | RISK PATIENTS | REPERFUSION THERAPY | SYMPTOM-ONSET | PRIMARY ANGIOPLASTY | FIBRINOLYTIC THERAPY | Myocardial Infarction - mortality | Myocardial Infarction - classification | Humans | Immunoglobulin Fab Fragments - adverse effects | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Immunoglobulin Fab Fragments - therapeutic use | Recombinant Proteins - adverse effects | Tissue Plasminogen Activator - adverse effects | Angioplasty, Balloon, Coronary | Fibrinolytic Agents - adverse effects | Myocardial Infarction - therapy | Time Factors | Electrocardiography | Female | Cerebral Infarction - chemically induced | Double-Blind Method | Kaplan-Meier Estimate | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Combined Modality Therapy | Recombinant Proteins - administration & dosage | Myocardial Infarction - complications | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Care and treatment | Abciximab | Coronary artery bypass | Comparative analysis | Health aspects | Heart attack | Angioplasty | Heart attacks | Intubation | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 03/2007, Volume 297, Issue 12, pp. 1332 - 1343
Journal Article
Journal of Cardiac Failure, ISSN 1071-9164, 2013, Volume 19, Issue 6, pp. 390 - 397
Journal Article
Journal Article
Heart Failure Reviews, ISSN 1382-4147, 5/2012, Volume 17, Issue 3, pp. 485 - 509
Journal Article
Journal Article
Journal Article
Journal Article